North America Percutaneous Mechanical Circulatory Support Devices Market to Grow at a CAGR of 13.6% to reach US$ 1,749.25 Million from 2020 to 2027

North America Percutaneous Mechanical Circulatory Support Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Intra-Aortic Balloon Pumps, VA-Extracorporeal Membrane Oxygenators (ECMO), and Short-Term Ventricular Assist Devices); End User (Hospitals, Ambulatory Surgical Centers, and Others); and Country

  • Report Code : TIPRE00018222
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 102
Buy Now

The North America percutaneous mechanical circulatory support devices market is expected to reach US$ 1,749.25 million by 2027 from US$ 645.23 million in 2019; it is estimated to grow at a CAGR of 13.6% from 2020 to 2027.

The increasing geriatric population, increasing prevalence of cardiovascular diseases and shortage of heart donors are the key factors driving the growth of percutaneous mechanical circulatory support devices. However, high costs of these devices and procedures associated with them as well as product recalls, and impact of COVID-19 pandemic on medical device industry is the major factor hindering the Percutaneous Mechanical Circulatory Support Devices market growth in North America.

Percutaneous mechanical circulatory support devices offers an effective and rapid approach to slow the downward spiral of hemodynamic instability among patients suffering with decompensated heart failures and cardiogenic shocks till a more definitive strategy is perceived among patients to recover from these cardiac ailments. The major roles of the percutaneous mechanical circulatory support devices include improving the native cardiac output, reducing ventricular volume and filling pressures, augmenting coronary perfusion, and maintaining vital organ perfusion.

Heart transplantation has been accepted as the best treatment for patients with medically refractory end-stage heart failure. A central fact about organ transplantation, and heart transplantation, in particular, is the scarcity of organs for transplant. Annual figures published by NHS Blood and Transplant in 2015, showed that there is still a vast shortage of organ donors. There are currently 286 patients on the waiting list for a heart transplant, compared with 126 in 2010. The number of people desperately waiting for a heart transplant has more than doubled in just five years, according to the latest statistics. According to a report published by Ottawa Heart Institute in April 2018, more than 5,000 Canadians could benefit from a heart transplant. However, only 170 transplants were performed annually in Canada due to chronic heart donor shortage.

Patients with advanced heart failure have a poor prognosis, and a heart transplant is still the best treatment option. However, the scarcity of donors, long waiting times, and an increasing number of unstable patients have favored the development of mechanical circulatory support.

Moreover, according to the Heart Failure Society of America, nearly 5.7 million Americans are suffering from heart failure. The data also suggests that almost 1.4 million persons with CHF are under 60 years of age. The Centers for Disease Control and Prevention (CDC) reports that about half of people who develop heart failure die within five years of diagnosis. The cost of heart failure in the US is estimated to be US$ 30.7 billion each year. According to the Mount Sinai Heart Center, every day in America, 33 people die in need of new organs, and about 115,000 people are languishing on waiting lists.

The chronic shortage of heart donors has also led to extend the age limits of donors in certain areas. Thus, the solution to this shortage of heart donors served by the temporarily used percutaneous mechanical circulatory support devices that are also helpful in long-term support for patients suffering from heart failures is likely to be adopted at higher rates in the coming years.

North America is witnessing the growing number of COVID-19 cases. Due to coronavirus spreading, many cities are shutting down, causing treatments and doctors/cardiologists appointment cancellation. Companies operating in the percutaneous mechanical circulatory support devices have limited their production of percutaneous mechanical circulatory support devices. As the treatment procedures are directly contacted with patients’ oral fluid that has a possible risk of infections, for the preventing the spread of COVID-19 it is requested to maintain social distancing as there is a greater risk of getting infected with coronavirus due to direct exposure to oral fluids of the patients. Thus, owing to these factors, the increased production for diagnostics test kits and ventilators are likely to hinder the growth of the percutaneous mechanical circulatory support devices market

Mexico Percutaneous Mechanical Circulatory Support Devices Market, Revenue and Forecast to 2027 (US$ Mn)

Mexico Percutaneous Mechanical Circulatory Support Devices Market, Revenue and Forecast to 2027 (US$ Mn)

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

NORTH AMERICA PERCUTANEOUS MECHANICAL CIRCULATORY SUPPORT DEVICES MARKET SEGMENTATION

By Product

  • Intra-Aortic Balloon Pumps
  • VA-Extracorporeal Membrane Oxygenation (ECMO)
  • Short-Term Ventricular Assist Devices (VADs)
    • Impella
    • Tandem Heart

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Country

  • US
  • Canada
  • Mexico

Company Profiles

  • Abbott
  • Teleflex Incorporated
  • Abiomed
  • Jarvik Heart, Inc
  • Medtronic
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, End User, and Country

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada

  1. Abbott
  2. Teleflex Incorporated
  3. Abiomed
  4. Jarvik Heart, Inc
  5. Medtronic

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to North America Percutaneous Mechanical Circulatory Support Devices Market